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Background: Breast cancer is the most frequent cancer among women worldwide, and the 
second most important cause of cancer death in developed countries after lung cancer. Early 
detection with mammographic screening reduces breast cancer mortality. Few studies have 
investigated factors associated with participation in The Norwegian Breast Cancer Screening 
Programme.  
Objective: To identify determinants for participation in the breast cancer screening 
programme in Norway by demographic, lifestyle and socioeconomic factors. 
Material and method: Cross-sectional study with data from the Norwegian Women and 
Cancer Study. Data collected in 2011, 8938 women aged 54-69 years. Self-reported behavior 
on lifestyle and socioeconomic factors collected by questionnaires. Logistic regression 
analysis with forward stepwise (likelihood ratio) selection was used to calculate odds ratios. 
Results: Approximately four of five women have participated in the Norwegian Breast 
Cancer Screening Programme. After covariates were adjusted for, determinants for 
participation in the screening program were young age, OR 0.57 (CI 0.49-0.66), having a 
mother without breast cancer, OR 1.60 (CI 1.26-2.04), high socioeconomic status and living 
in the western region of Norway. Abstaining from alcohol gave lower odds of participation. 
Conclusion: Our study found several determinants for participation in the screening program. 
There is a social gradient associated with participation, with increased participation in higher 
social classes. Measures to increase it should be directed specifically at women in lower 
social classes. Demography is also decisive for participation, while lifestyle factors were of 
less importance. 
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Breast cancer is a major public health issue on a global scale (1). It is the most frequent 
cancer among women worldwide, and it comprises > 20 % of all female cancers (2, 3). In 
2015, 3415 new cases were diagnosed in Norway (2). Breast cancer is the most common 
cause of cancer death among women, and the second most common cancer death after lung 
cancer in developed countries (3). Early detection with mammographic screening are 
associated with a reduction in breast cancer mortality (4). Breast cancer screening is 
recommended in Norway regardless of being in a risk group or not (2). Few studies have been 
conducted to investigate factors that are associated with participation. By mapping 
determinants for participation in the screening program, and by identifying non-participants, 
the program can be customized in order to increase the participation and further reduce the 
breast cancer mortality in the future.  
 
1.2 Screening 
Primary prevention measures involve improving health and reducing risk of developing 
invasive cancers or other diseases in the general population (5). These measures may include 
reduced alcohol consumption, a healthy diet and other lifestyle modifications (5). When it 
comes to breast cancer, it may not be socially accepted to change behavior, or difficult to 
remove some of the specific risk factors. This is why secondary preventive measures are 
developed (6). Screening is a form of secondary prevention which aims to discover disease 
among asymptomatic individuals. The central idea with screening programs is early disease 
detection and treatment (6). Screening programs seeks to test large numbers of individuals for 
one or more risk factors or diseases, on a voluntary basis (5). The Norwegian Breast Cancer 
Screening Program is a quality assured program that became nationwide in Norway in 2004 
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(7). Its primary target is to reduce breast cancer mortality with 30 % among the invited 
women (7). Women aged 50-69 years are invited, and recommended, to participate in the 
program every other year. Through this 20 year period each of the women are invited to 
participate 10 times (7). The mammographic screening is done at a stationary or mobile breast 
diagnostic center, which is placed central in the different Norwegian counties. The 
examination is performed with two projections on each breast (8). If the mammographic 
images show any suspicious findings, the women are summoned to further examinations that 
might include new radiologic projections, ultrasound and/or biopsy (8). Approximately 76 % 
of the invited women participate in each screening round, while 83 % of the invited women 
have participated at least once (9). The Norwegian quality manual indicates that it is 
necessary to have a participation rate on at least 75 % for the breast cancer screening program 
to be cost effective (10). One important disadvantage with the breast cancer screening 
program is the phenomenon of overdiagnosis, where breast cancer is diagnosed at screening 
when it would not have been detected in the absence of the program (11). It is not possible to 
determine whether or not the individual case of breast cancer is a case of overdiagnosis. This 
may lead to unnecessary treatment for the women, mental strain and an increased use of 
resources in the healthcare system (11). A cancer diagnosis in itself may cause substantial 
impact on both the mental and physical quality of life. The prognosis of breast cancer is 
strongly dependent on stadium of the disease, which can be affected by early diagnostics (11). 
The latest results from The Norwegian Breast Cancer Screening Program showed that 
participants had 43 % lower breast cancer mortality relative to non-participants (12). Various 
research show inconsistent results, and mortality risk reduction varies according to age of 
screening, among other factors (3). Women can also be examined with mammographic 
imaging after referral from a physician, if there is any suspicion of malignancy in the breast. 
This is referred to as opportunistic screening (11).   
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1.3 Risk factors  
There are several established risk factors for breast cancer (8, 13). Menarche at an early age is 
associated with an increased risk, as higher number of menstrual cycle‟s results in a higher 
cumulative dose of estrogen (8). Women who give birth to their first child after the age of 35 
have a significant increased risk of developing breast cancer relative to women who give birth 
before the age of 20 (13). There is a general consensus that multiparity has a protective effect 
on breast cancer (1, 13). Menopausal age are also of importance, and late menopause after the 
age of 55 are associated with 30 % higher risk of breast cancer relative to those who reaches 
menopausal age before 45 years (8). Hormone replacement therapy is a known carcinogen, 
and women using estrogen and progestin preparations combined has 26 % increased risk of 
breast cancer (14, 15), with a declining risk 2-3 years after treatment cessation (15). Among 
women who participated in the Norwegian Breast Cancer Screening Programme between 
1996-2004, ever use of hormone therapy was associated with 58 % increased risk of breast 
cancer than never use (16). 
 
Approximately 5 % of all breast cancers are hereditary, and the hereditary component is most 
prominent if first-born relatives as mother, sister or daughter have had premenopausal breast 
cancer (8). Both nutrition and physical activity might be significant factors on breast cancer 
risk. Studies show that postmenopausal overweight is associated with an increased risk of 
breast cancer, while premenopausal overweight has a protective effect (8). Alcohol and 
tobacco consumption are closely correlated (17), but whilst high alcohol consumption has 





1.4 Health and social inequality  
A lot of research is conducted on social inequalities and its effect on health (18). People with 
higher educational levels, income and a high status profession have on average increased life 
expectancy and better health, relative to those with lower educational level, income and a low 
status profession (18). This is known as the social gradient in health. There are clear 
tendencies that bad health-habits pile up in groups with low socioeconomic status, in 
opposition to those in groups with higher socioeconomic status (18). In example, marked 
gradients are found on education for nutrition and physical activity (19). However, the 
association between alcohol consumption and socioeconomic status is more complex, as 
women in high social classes have on average higher alcohol consumption, and drink more 
often than women in lower social classes (20). In lower social classes the social gradient in 
health is often associated with an increased risk of diseases related to in example diet and 
diabetes mellitus, smoking and lung cancer (19). In contrast to this, there is an opposite social 
gradient related to breast cancer, as women in higher social classes have an increased risk of 
the disease (11).  
 
Health services play a small but important role in social inequalities in health. The primary 
aim is for everyone to experience the same level of safety for life and health (18). This is a 
challenge even in Norwegian policy. The use of health services vary with social status and 
this might strengthen the already existing inequalities (21, 22). Although there is a lack of 
research on preventive health services, it is known that high-status groups are more frequent 





1.5 Aim of the study 
We want to describe factors that might be of relevance to find determinants for participation 
in the screening programme. With data from the Norwegian Women and Cancer Study we 
have the opportunity to describe possible associations between demographic, lifestyle and 
socioeconomic factors, and participation. 
 
1. To investigate if participation in the Norwegian Breast Cancer Screening 
Programme varies with demographic, lifestyle and socioeconomic factors.  
2. To identify if there is an association between the known breast cancer risk factors 























2 Material and method 
 
2.1 The Norwegian Women and Cancer Study 
Quantitative research methods are used in this thesis, with data collected in the Norwegian 
Women and Cancer Study (NOWAC). The NOWAC is a prospective cohort study with a 
nationwide sample of Norwegian women aged 30-70 years old (24). The subjects were 
randomly sampled from the Norwegian Central Person Register, and the collection of data 
began in 1991. The data is collected through different series of self-reported questionnaires of 
2-8 pages, with various questions. Over 170 000 Norwegian women have participated over 
the years (24). The original purpose of the NOWAC was to study the relationship between the 
use of external and internal hormones and female cancers, particularly breast cancer (24). The 
study has expanded over the years, by adding questions about diet, sun habits and 
mammography among others. In addition to this, blood-samples and tumor tissue have been 
collected (24). The data has been used to shed light on other problems as associations between 
fish consumption, vitamin D intake, smoking, sun habits and cancer (24). The NOWAC has 
been validated (25), and a number of articles have been published based on data collected in 
this study (26, 27).            
 
2.2 Selection 
The selection used in this cross-sectional study was women who responded on the 
questionnaires from series 35 from 2003, and series 47 from 2011 (figure 1). Two questions 
regarding number of children and education were included from series 35, as these questions 
did not exist in series 47. No subjects were excluded from our cohort from series 47, resulting 
in a study population of 8938 subjects aged 54-69 years. The questionnaire in series 47 
consists of 8 pages and was chosen because it contained the latest data collected on the 
women in the NOWAC (see appendix). In 2011 the breast cancer screening program had been 
 
8 
operative throughout Norway for 7 years. The questionnaire from series 47 includes questions 
















2.3.1 Dependent variable 
The variable “How many times have you been examined with mammography after invitation 
from the Cancer Registry/The National Mammography Screening Program” (continuous) was 
dichotomized into the variable “Screening” with the categories: participation and no 
participation. This is the dependent variable, as the outcome of interest was participation in 
the breast cancer screening program. Participation means that they have taken a mammogram 
at least once through the Norwegian Breast Cancer Screening Programme. The dependent 
variable was analyzed against all the independent covariates in the main regression analysis. 
Missing was included as „no participation‟ in the screening variable.  
 
2.3.2 Independent variables 
The following variables were selected as a result of a literature review on the topic, and what 




Age (continuous) was dichotomized into the categories: 54-60 years and 61-69 years. The 
youngest age group was used as the reference group. 
 
Region 
Municipality (municipality number, continuous) was categorized into five regions:  
 South-East (includes Østfold, Akershus, Hedmark, Oppland, Buskerud, Vestfold, 
Telemark, Aust-Agder and Vest-Agder) 
 Oslo  
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 West (includes Rogaland, Hordaland and Sogn og Fjordane) 
 Mid (includes Møre og Romsdal, Sør-Trøndelag and Nord-Trøndelag) 
 North (includes Nordland, Troms and Finnmark) 
Information about municipality and birth year was collected from Statistics Norway and 
linked to the data file (28). South-East was used as the reference group. 
 
Children  
Number of children (continuous) was categorized into three groups: none, 1-2 and 3+. “None” 




From the variables „Have you smoked more than 100 cigarettes in your life‟ and „Do you 
smoke on a daily basis‟, the variable „Smoking status‟ was constructed. It was categorized 




This variable was based on a question were the subjects rated their level of physical activity 
on a scale from 1-10, where 1 = very low and 10 = high. The original variable was 
categorized into three groups: low (≤ 4), moderate (5-7) and high (≥ 8). Low physical activity 







The first question the subjects needed to answer in regards to alcohol consumption was if they 
were a teetotaler, followed by a question of average alcohol consumption during the recent 
year. “If no, how frequent and how much did you drink on average the recent year”. Subjects 
answered by ticking the appropriate box: beer, wine, liquor or liqueur. It ranged from never, 
rarely, 1 per month, 2-3 times per month, 1 per week, 2-4 times per week, 5-6 times per week 
or 1 or more per day. The original variable was continuous and measured alcohol 
consumption in grams per day. It was categorized into three groups for comparison between 
the groups: none (0 grams), ≤ 3 units/week (0.01-5.14 g/day) and > 3 units/week (5.15-35.0 
g/day). A glass of wine, or 1 unit of alcohol, equals approximately 12 grams of pure alcohol 
(29). ≤ 3 units/week was used as the reference group.  
 
Body mass index 
Body mass index was computed from the variables height and weight (calculated with weight 
in kg/(height in cm * height in cm/10 000)). Body mass index was categorized into 4 groups: 
underweight (BMI <18.5), normal (BMI 18.5-24.9), overweight (BMI 25-29.9) and obesity 
(BMI ≥ 30), based on World Health Organization‟s classification of body mass index (30). 
Those in the normal weight group were used as the reference group. 
 
Hormone replacement therapy 
From the variables „Have you ever used hormone replacement therapy‟ and „Do you use 
hormone replacement therapy now‟ the variable „Hormone replacement status‟ was 
constructed and included with three categories: current, former and never . Missing was 




Breast cancer in mother 
Subjects answered the question whether or not their mother has had breast cancer, by ticking 
the appropriate box: yes, no or don‟t know. Those who ticked the yes-box were used as the 
reference group. 
 
Socioeconomic factors  
Education  
Education in total number of years (continuous) was categorized into three groups: 7-12 
years, 13-15 years and 16-30 years, based on the Norwegian school system. The subjects with 
7-12 years of education were used as the reference group.  
 
Gross household income 
The subjects answered the question “How much is the gross household income per year” in 
Norwegian kroner (NOK). The subjects were given seven alternative boxes to tick: up to 
150 000, 151 000-300 000, 301 000-450 000, 451 000-600 000, 601 000-750 0000, 751 000-
900 000 or > 900 000. This variable was collapsed into three groups: 0-300 000, 301 000-




The subjects were given four optional boxes to tick for the question “How do you perceive 
your own health”: very good, good, bad or very bad. These four categories were collapsed 
into three: bad (very bad + bad), good and very good. Those who perceived their own health 




2.4 Statistical analysis 
All statistical analyzes were performed using the statistical package SPSS, version 24.0. 
Continuous variables or variables with many response categories were dichotomized or 
categorized, as described under section 2.3. Characteristic variables are reported as count with 
percentages in each category, to see the distribution of participation/non-participation in all 
the included variables. A chi-squared test was used to test the association between each 
covariate against screening (table 1). The significance level was set at 0.05 in all analyzes, 
and all reported p-values are two-tailed. A multivariate logistic regression model using 
forward stepwise (likelihood ratio (LR)) selection was chosen as the appropriate method for 
analyzing the data, with a binary dependent variable. The dependent variable in the analysis 
was screening, and all the independent covariates included are accounted for under section 
2.3. Odds ratios (OR) with 95 % confidence intervals (CI) are provided. OR is different from 
relative risk (RR), but closely related. RR is a ratio of probabilities which can be expressed in 
terms of a risk ratio, or estimated by an OR. If the studied disease is rare, then OR and RR is 
usually comparable. If the disease is more common the OR can overestimate and magnify risk 
(6). All independent covariates were adjusted for, and entered as three different blocks in the 
model. Block 1 included the demographic variables, block 2 included lifestyle variables and 
block 3 included the socioeconomic variables. Variables were included based on previous 
findings in the literature, and established breast cancer risk factors. The Hosmer-Lemeshow 
test (Goodness-of-Fit test) was satisfactory with a p-value = 0.062.  
 
2.5 Ethics 
The Norwegian Women and Cancer study is approved by the Regional Committees for 










3.1 Selection characteristics  
See table 1 for distribution of the relevant covariates by participation in the Norwegian Breast 
Cancer Screening Programme. 
 
Minimum and maximum age among the subjects was 54 and 69 years, respectively. The mean 
age was 60 years. There was 87 % participation in the age-group 54-60 years, while it was 
almost 10 percentage points lower participation in the age-group between 61-69 years, with 
77.4 % (p= < 0.01). The majority of the subjects lived in Oslo and the South-East region (56.1 
%). The two regions with the highest and lowest participation were West with 84.9 %, and 
Oslo with 77.8 % (p= < 0.01). The mean number of children was 2. Subjects with 1-2 children 
tended to participate a little less (82.0 %) than those with no children (82.5 %), and those with 
3+ children (83.3 %). 
 
There was 83.2 % participation for current smokers, 82.2 % for former smokers and 84.4 % 
for never smokers. For subjects who reported low physical activity there was 82.5 % 
participation. The participation tended to increase with the next level of activity, to 84.6 %, 
while it dropped back to 83.0 % in the group with the highest level of activity. The mean 
intake of alcohol was 2.5 units per week. The group with no alcohol intake had the lowest 
participation with 78.0 %, while the group with an alcohol intake > 3 units per week had 83.8 
% participation (p= < 0.01). Minimum and maximum BMI was 14.5 and 71.0, respectively. 
The mean BMI was 25.6, and classifies the average woman in the study as slightly 
overweight. This group (BMI 25-29.9) had the highest share of participants with 84.2 %, 
whilst the group with the lowest share of participants had BMI < 18.5, with 74.6 % (p= 0.04). 
Current users of hormone replacement therapy had 82.8 % participation, while former use had 
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80.8 %, and never use had 83.4 % participation (p= 0.02). Women with a mother who have 
had a breast cancer diagnose participated less in the national screening programme (78.2 %) 
than those with mothers without breast cancer (84.1 %) (p= < 0.01).  
 
Minimum years of education were 7 years, while maximum was 30 years. Mean years of 
education was 13.4. Subjects with the highest level of education participated more (84.6 %), 
than those with the lowest level of education (81.9 %) (p= 0.02). The subjects in the lowest 
income group (0-300 000) participated less than those in the highest income group (> 
600 000) with 76.0 % and 85.9 %, respectively (p= < 0.01). There was no difference in 
screening participation inside the Oslo region when income was adjusted for (Data not 
shown). The participation increased with better health. Those who reported bad health had 















Table 1: Characteristics of the covariates for breast cancer screening from The Norwegian Women and Cancer 
Study, 2011 (N=8938) 











   
< 0.01 
54-60 years 618 (13.0) 4134 (87.0)  




   
< 0.01 
South-East 727 (17.5) 3419 (82.5)  
Oslo 193 (22.2) 675 (77.8)  
West 266 (15.1) 1495 (84.9)  
Mid 246 (18.5) 1085 (81.5)  




   
0.28 
None 133 (17.5) 626 (82.5)  
1-2 898 (18.0) 4081 (82.0)  
3+ 533 (16.7) 2667 (83.3)  
 
Smoking status  
 
   
0.13 
Current 232 (16.8) 1153 (83.2)  
Former 963 (17.8) 4445 (82.2)  
Never 205 (15.6) 1112 (84.4)  






   
0.08 
Low 276 (17.5) 1303 (82.5)  
Moderate 730 (15.4) 4023 (84.6)  
High 272 (17.0) 1331 (83.0)  




   
< 0.01 
None 289 (22.0) 1024 (78.0)  
≤ 3 units/ week 744 (16.6) 3745 (83.4)  
> 3 units/ week 452 (16.2) 2337 (83.8)  








Table 1 continues. 
 









Body mass index  
 
   
0.04 
Underweight < 18.5 29 (25.4) 85 (74.6)  
Normal 18.5-24.9 714 (16.6) 3575 (83.4)  
Overweight 25-29.9 484 (15.8) 2570 (84.2)  
Obesity ≥ 30 208 (17.6) 977 (82.4)  






   
0.02 
Current 168 (17.2) 811 (82.8)  
Former 535 (19.2) 2252 (80.8)  





   
 
< 0.01 
Yes 144 (21.8) 517 (78.2)  
No 1194 (15.9) 6314 (84.1)  
Don‟t know 21 (22.3) 73 (77.7)  




   
0.02 
7-12 years 701 (18.1) 3171 (81.9)  
13-15 years 375 (16.9) 1850 (83.1)  
16-30 years 373 (15.4) 2044 (84.6)  






   
< 0.01 
0-300 000  264 (24.0) 836 (76.0)  
301 000-600 000 586 (17.0) 2867 (83.0)  
> 600 000 558 (14.1) 3394 (85.9)  








 157 (21.7) 565 (78.3)  
Good 914 (17.1) 4433 (82.9)  
Very good 376 (14.4) 2238 (85.6)  
Missing 117 (45.9) 138 (54.1)  
aThe chi-square statistic is significant at the 0.05 level 
bMeasured on a scale from 1-10. Low (≤ 4), Moderate (5-7), High (≥ 8) 
cUse of hormone replacement therapy 
dGross income per household in NOK 
eVery bad + bad perception of own health 
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3.2 Univariate analysis 
Table 2 shows the results from the univariate analyzes between screening and each of the 
covariates. Those in the highest age group had 49 % lower odds for participating in the 
screening programme than the youngest age group (OR= 0.51, 95 % CI 0.46 – 0.57). Those 
living in Oslo had 26 % lower odds for participation (OR= 0.74, 95 % CI 0.62 – 0.89), but 
living in the West region was associated with 20 % higher odds of participation (OR= 1.20, 
95 % CI 1.03 – 1.39) relative to the South-East region. Women with no alcohol consumption 
had 30 % lower odds for participating (OR= 0.70, 95 % CI 0.60 – 0.82) than those with a 
consumption ≤ 3 units/week. To be underweight gave 41 % lower odds of participation (OR= 
0.59, 95 % CI 0.38 – 0.90) than those in the normal weight group. Those with mothers who 
had not experienced breast cancer had 48 % higher odds of participation (OR= 1.48, 95 % CI 
1.21 – 1.79) than those with mothers who have had a breast cancer diagnose. Having the 
highest level of education (16-30 years) were associated with 21 % higher odds of 
participation (OR= 1.21, 95 % CI 1.06 – 1.39) than having the lowest level of education (7-12 
years). Living in a household with a gross income between 301 000 – 600 000 gave 55 % 
higher odds for participation (OR= 1.55, 95 % CI 1.31 – 1.82), while an income > 600 000 
(1.92, 95 % CI 1.63 – 2.27) gave 92 % higher odds of participation than those in the lowest 
income group (0 – 300 000). Those who perceived their own health as good had 35 % higher 
odds of participating (OR= 1.35, 95 % CI 1.11 – 1.63) relative to those who perceived their 
own health as bad. Those who perceived their own health as very good had 65 % higher odds 







Table 2: Univariate logistic regression with odds ratio (OR) for participation in The Norwegian Breast Cancer 









54-60 years (ref) 1.00  





South-East (ref) 1.00  
Oslo 0.74 0.62-0.89 
West 1.20 1.03-1.39 
Mid 0.94 0.80-1.10 





None (ref) 1.00  
1-2 0.97 0.79-1.18 
3+ 1.06 0.86-1.31 
 
Smoking status  
 
  
Current (ref) 1.00  
Former 0.93 0.79-1.09 







Little (ref) 1.00  
Moderate 1.17 1.00-1.36 





None 0.70 0.60-0.82 
≤ 3 units/ week (ref) 1.00  














OR 95 % CI 
 
Body mass index  
 
  
Underweight < 18.5  0.59 0.38-0.90 
Normal 18.5-24.9 (ref) 1.00  
Overweight 25-29.9 1.06 0.94-1.20 







Current (ref) 1.00  
Former 0.87 0.72-1.06 
Never 1.04 0.87-1.24 
 
Breast cancer mother 
 
  
Yes (ref) 1.00  
No 1.48 1.21-1.79 





7-12 years (ref) 1.00  
13-15 years 1.09 0.95-1.25 







0-300 000 (ref) 1.00  
301 000-600 000 1.55 1.31-1.82 







 (ref) 1.00  
Good 1.35 1.11-1.63 
Very good 1.65 1.34-2.04 
aUnivariate analyzes between screening and each of the covariates 
bMeasured on a scale from 1-10. Low (≤ 4), Moderate (5-7), High (≥ 8) 
cCurrent or ever use of hormone replacement therapy 
dGross income per household in NOK 







3.3 Determinants for participation 
The covariates children, smoking status, physical activity, body mass index, hormone 
replacement status, education and health status were excluded in the final regression model as 
they did not contribute to predicting participation in the Norwegian Breast Cancer Screening 
Programme. 
 
Table 3 shows the significant associations between the covariates in the final regression 
model and participation in the screening program. Women in the oldest age group (61-69 
years) had 43 % lower odds of participating in the Norwegian Breast Cancer Screening 
Programme than those in the youngest age group (OR= 0.57, 95 % CI 0.49 – 0.66). Women 
with a mother who had not experienced breast cancer had 60 % higher odds of participation 
than those with mothers who have had breast cancer (OR= 1.60, 95 % CI 1.26 – 2.04). The 
odds of participation increased as the gross income increased. Living in a household with a 
gross income between 301 000 – 600 000 gave 43 % higher odds of participating than those 
with a gross income between 0 – 300 000 (OR= 1.43, 95 % CI 1.14 – 1.78). Having an 
income > 600 000 gave 50 % higher odds of participation relative to those in the lowest 
income group (OR = 1.50, 95 % CI 1.20 – 1.90). Teetotalers had 31 % lower odds of 
participating than those who consumed ≤ 3 units per week of alcohol (OR= 0.69, 95 % CI 
0.56 – 0.86). There were 32 % lower odds for participation for those living in Oslo relative to 
those in the South-East region (OR= 0.68, 95 % CI 0.54 – 0.86), whilst residency in the West 







Table 3: Multivariate logistic regression with odds ratio (OR) for participation in the Norwegian Breast Cancer 









54-60 years (ref) 1.00  





South-East (ref) 1.00  
Oslo 0.68 0.54-0.86 
West 1.39 1.11-1.73 
Mid 0.83 0.68-1.03 





None 0.69 0.56-0.86 
≤ 3 units/week (ref) 1.00  
> 3 units/week 0.93 0.79-1.10 
 
Breast cancer mother 
 
  
Yes (ref) 1.00  
No 1.60 1.26-2.04 







0-300 000 (ref) 1.00  
301 000-600 000 1.43 1.14-1.78 
> 600 000 1.50 1.20-1.90 
aLogistic regression model with forward stepwise (Likelihood Ratio (LR)) selection, mutually adjusted 
bGross income per household in NOK 
 
















4.1 Main findings 
We found a social gradient in participation, with less participation in the Norwegian Breast 
Cancer Screening Programme in lower social classes. Demographics are also decisive for 
whether the women participate or not. We also found that lifestyle factors were of less 
importance for participation in the screening programme. 
 
4.2 Comparison with previous findings  
Socioeconomic status is mentioned to have an impact on public health, and that high 
socioeconomic status is associated with better health (31). The results of our study suggest a 
social gradient in participation, with more participation for women with higher educational 
levels and with high gross income, compared to lower levels. Income follows educational 
level and our results shows multicollinearity between the two covariates. Education is 
excluded from the final model as a result of the stepwise selection. The OR for participation 
in the highest income group was reduced in the multivariate analysis, after adjusting for the 
other covariates. Studies conducted in Norway and Sweden found that higher educational 
levels were associated with an increased risk of breast cancer (32). This was explained by 
established breast cancer risk factors as higher alcohol consumption among these women, that 
they have fewer children, and that they use hormone replacement therapy to a greater extent 
than lower educated women (27, 32). These known risk factors for breast cancer might also 
influence that higher educational levels and income is associated with higher participation 
than lower educational levels and less income. Participation in the screening program also 
implies costs like deductibles, travel expenses and absence from work, which must be partly 
covered by one self (11). This might be a factor that contributes to less participation among 
women with low income. We also found that bad health status was associated with less 
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participation than good health status (table 1). Our finding of less participation in lower social 
classes, and for women with poorer health, corresponds to other findings that there are social 
inequalities in Norway. Richer and healthier people are usually more frequent users of health 
services (23). A Swedish study suggests that low social participation, low sense of control and 
being under great stress is associated with higher odds of non-participation (33). Considering 
how substantial impact a cancer diagnosis might have on both the mental and physical health, 
this might be of importance for the non-participants who experience lack of control and social 
participation, and are under stress. Some might have chosen not to participate based on their 
knowledge about overdiagnostics, and the potential unnecessary harm it may cause (11). 
Other subjects included might have undertaken opportunistic mammography after referral 
from a physician, and have therefore not participated through the national screening program. 
We have not included information about the women‟s use of opportunistic screening in our 
study.  
 
We found an association between the use of hormone replacement therapy and participation 
in the screening program (table 1). According to clinical guidelines, women who use 
menopausal hormone therapy are especially recommended mammography screening in the 
Norwegian Breast Cancer Screening Programme (34), as it is a known risk factor and has a 
key role in development and progression of breast cancer (1). 43 % of the women who 
participated in the Norwegian Breast Cancer Screening Programme between 1996 and 2004 
reported to had ever used hormone therapy (16), which corresponds to our finding of 41.5 %. 
Prescriptions for hormone replacement therapy are most frequent for women in the age-group 
55-59 years (35), which corresponds to our finding that the odds of participation are higher in 
the age-group between 54-60 years than 61-69 years. The higher odds of participation in the 
lowest age group might also be seen in relations to the average age for breast cancer being 
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approximately 59 years in Norway (8). Another study conducted in Norway found that 
women in the age-group 62-67 participated most in the Norwegian Breast Cancer Screening 
Programme (36). This deviates from our finding. A possible explanation to the difference 
might be that not all of the women in the oldest age-group in our study had gotten invitations. 
They could have lived in municipalities where there was no breast cancer screening until it 
became nationwide in 2004 (7).    
 
Women with a first degree relative diagnosed with breast cancer have an elevated risk of 
breast cancer compared to women without an affected family member (37). Our findings 
suggest that family history of breast cancer affects participation in the screening program. The 
odds of participation are higher if there is no history of breast cancer in their mothers. In 
Norway, women with known high familial risk of breast cancer is offered more intensive 
follow-up than public mammography screening (7). Women with detected BRCA1 and 
BRCA2-gene mutation are offered annual MR-examination of the breasts up to the age of 70 
(7), which exclude them from the national screening program. Women with an increased risk 
of breast cancer based on family history, without detection of gene-mutation, are offered 
tailored mammography examinations from the age of 30 (7). At the age of 60, these women 
can be transferred to screening in the Norwegian Breast Cancer Screening Programme with 
invitations every other year (7). This supports our finding that there is less participation 
among women with a family history of breast cancer.  
 
Participation in the Norwegian Breast Cancer Screening Programme varies according to 
counties or regions (8). We found that there was approximately 85 % participation in the West 
region, and almost 78 % in Oslo. This corresponds to findings in other research where the 
highest participation is in counties in the west region, while residents in Oslo participate less 
 
28 
through the screening program (8, 36). The lower odds of participation in the Oslo region 
might be influenced by the many private clinics there, and that some groups of women may 
have taken advantage of this option. Private screening for breast cancer is a more expensive 
alternative to the national screening program (11). Cultural background and language barriers 
might also be a contributory reason to less participation in Oslo, where the highest 
proportions of immigrants are located in Norway (8). 6 % of women aged 50-69 years had 
undertaken mammography in a private clinic in 2005 and 2008, on a nationwide basis (8). We 
did not find a difference in participation based on income level inside of Oslo. Travel 
expenses might be lower in Oslo as there are shorter distances than in the West region. This 
does not appear to be decisive for the participation, as it is lower in Oslo than in the western 
part of Norway.  
 
We found that the average consumption of alcohol was 2.5 units per week, which is a little 
less than what has been found elsewhere (17). Their finding was that the average alcohol 
consumption were 3.5 units per week, and their results suggests that about 4 % of the breast 
cancers in developed countries are attributable to alcohol (17). No alcohol consumption was 
associated with lower odds of participating in the screening program relative to those with a 
consumption ≤ 3 units per week. Above 50 % of the subjects included in our study reported to 
consume ≤ 3 units of alcohol per week. This might be considered as normal consumption, as 
the average consumption is shown to be 2.5 units per week. Women with no alcohol 
consumption were a small group of approximately 15 %. It is not known whether abstaining 
from alcohol is related to religion, diseases or other. We chose not to include information 
about diseases in the study. This could be a potential confounder relative to lifestyle and 
socioeconomic factors, and the odds of participation. Higher odds of participation in the 
group with normal alcohol consumption might be related to the known association between 
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drinking alcohol and the risk of breast cancer. We also found a tendency that women with a 
consumption > 3 units per week participated less than those with a normal consumption, but 
the results were not statistically significant Smoking is also a known risk factor for various 
cancer forms, but smoking has shown inconsistent results on the risk of developing breast 
cancer (17). We found no association between smoking status and participation in the 
screening program.  
  
Reproductive patterns have an impact on the risk of breast cancer (1). Women who give birth 
to her first child after the age of 35 have a particularly high risk of developing breast cancer, 
relative to those who give birth before the age of 20. High parity seems to have a protective 
effect on breast cancer (8). We did not find an association between number of children and 
participation in the Norwegian Breast Cancer Screening Programme in our study, suggesting 
that the risk associated with parity is not relevant for deciding whether or not to participate.  
 
A meta-analysis conducted in 2013 found that the average breast cancer risk reduction 
associated with being physically active was 12 % (38). National guidelines in Norway 
recommend people to be physically active to reduce the risk of developing cancer (39). We 
found no association between physical activity and participation in the screening program, 
which suggests that this risk factor is not relevant for participation. There is a known 
association between body mass index and physical activity (38). We found that underweight 
women had lower odds of participation than women in the normal weight group. This 
difference might be related to the difference in risk of breast cancer (40). It could be easier to 
feel a tumor themselves if being underweight, which could lead to opportunistic screening. 
The possible discomfort related to the examination if the breasts are very small might also be 
a contributor to less participation in this group (11). Underweight might be caused by other 
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diseases, which again can affect the participation rate for various reasons. We found that the 
average woman in our study was slightly overweight. It is known that the risk of breast cancer 
increase with weight gain in adulthood (40). We do not have information about any changes 
in weight, other than that the prevalence of overweight and obesity has increased in 
Norwegian women during the last decades (41).  
 
4.3 Methodological considerations 
 
4.3.1 External validity 
The response rate in the NOWAC has varied with length of the questionnaires, geography and 
age. Several validation studies have been conducted and shown that the distribution of 
exposures was independent of the response rate (24). A postal survey conducted on non-
responders in the NOWAC showed that lack of time and privacy was the most important 
reasons for not responding to the questionnaires (25). No differences were found in lifestyle-
factors when comparing responders to non-responders. No significant differences were found 
in age and education when the selection of participants from the first to the second mailing 
was studied. This indicates good external validity (24, 25). The proportion of participants in 
the Norwegian Breast Cancer Screening Programme in our study corresponds to findings in 
other research about Norwegian women‟s participation rate (36). Based on these findings, it is 
therefore reason to believe that the sample is representative of the female population in 
Norway in the same age group.   
 
4.3.2 Strengths 
Information about age and municipality was collected from Statistics Norway and is unlikely 
erroneous. Variables as the use of hormone replacement therapy, physical activity and self-
reported height and weight (body mass index) is validated, without any measurement errors 
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found (24, 42). The main variable of interest, screening, has been validated by linkage to the 
Norwegian Breast Cancer Screening Programme (24). This linkage has shown that 1.7 % of 
the participants in the Norwegian Breast Cancer Screening Programme answer the question 
about participation negatively as no participation in the NOWAC questionnaire (unpublished 
material, Lund E 2017). Selection bias occurs if non-responders differ from responders. The 
risk of selection bias is reduced by having data from a large nationwide female cohort.  
 
4.3.3 Limitations 
Self-reported data from questionnaires are prone to reporting bias. This self-reporting might 
lead to over-reporting of healthy habits as physical activity and education, and under-
reporting of what is considered unhealthy. This might include questions regarding high 
weight (body mass index) and alcohol consumption. These factors could pose a risk of bias. 
Matters that subjects can find sensitive or difficult to report might be prone to bias. Over-
reporting of physical activity or under-reporting of alcohol consumption might lead to an 
over- or underestimation of the odds for participating in the breast cancer screening program. 
Residual confounding might be an issue, as variables not included in the thesis could have an 
impact on the proportion of participants in the screening program. Not all of the variables 
have been validated (24). 
 
When participants are compared to non-participants in an invited population, this could 
introduce systematic error through self-selection (11). This might lead to a distortion of the 
results away from the true estimate. Women who participate in the screening program differ 
from non-participants in aspects that are related to their risk of breast cancer and/or the risk of 
breast cancer mortality (11). The possibility of self-selection therefore constitutes a limitation 













This study shows that there are differences between participants and non-participants in the 
Norwegian Breast Cancer Screening Programme. The study reveals that there is less 
participation in the Oslo region, which can be a result of many private screening clinics, and 
high immigration rates. There is also a social gradient where poor health is associated with 
less participation, and that participation increase with increased income. We found that 
lifestyle factors as smoking, physical activity and body mass index were less important for 
participation in the screening program.  
 
The study results indicate that measures to increase participation in the screening program 
should be directed specifically at women in lower social classes, especially considering that 
these women are likely to be in poorer health in the first place (23, 31). Reduced deductibles 
for women in low income-groups might be a measure to increase the participation. Also, the 
aspect of the demographic differences needs to be considered if the aim is to increase the 
participation in regions as Oslo. From a public health perspective, socioeconomic status is 
important to take into account when addressing the problem of non-participation in breast 
cancer screening in Norway. A high participation rate is also favorable in a socioeconomic 
perspective, considering the resources allocated to the screening programme (43).     
 
 
5.1 Future studies 
It might be useful to conduct more research among groups with low socioeconomic status and 
immigration groups, and their use of preventive health care services in Norway. This would 
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